EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H36O7 |
| Net Charge | 0 |
| Average Mass | 424.534 |
| Monoisotopic Mass | 424.24610 |
| SMILES | [H][C@@]12C(=C[C@@H](O)C[C@@H]1OC(=O)[C@@H](C)CC)C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(=O)O |
| InChI | InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1 |
| InChIKey | TUZYXOIXSAXUGO-PZAWKZKUSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | environmental contaminant Any minor or unwanted substance introduced into the environment that can have undesired effects. Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. xenobiotic A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor Any EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that inhibits HMG-CoA reductases. Hydroxymethylglutaryl-CoA reductase inhibitors have been shown to lower directly cholesterol synthesis. The Enzyme Commission designation is EC 1.1.1.34 for the NADPH-dependent enzyme and EC 1.1.1.88 for an NADH-dependent enzyme. |
| Applications: | anticholesteremic drug A substance used to lower plasma cholesterol levels. anticholesteremic drug A substance used to lower plasma cholesterol levels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pravastatin (CHEBI:63618) has functional parent (S)-2-methylbutyric acid (CHEBI:38655) |
| pravastatin (CHEBI:63618) has functional parent (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid (CHEBI:63655) |
| pravastatin (CHEBI:63618) has role anticholesteremic drug (CHEBI:35821) |
| pravastatin (CHEBI:63618) has role environmental contaminant (CHEBI:78298) |
| pravastatin (CHEBI:63618) has role metabolite (CHEBI:25212) |
| pravastatin (CHEBI:63618) has role xenobiotic (CHEBI:35703) |
| pravastatin (CHEBI:63618) is a 3-hydroxy carboxylic acid (CHEBI:61355) |
| pravastatin (CHEBI:63618) is a carbobicyclic compound (CHEBI:36785) |
| pravastatin (CHEBI:63618) is a carboxylic ester (CHEBI:33308) |
| pravastatin (CHEBI:63618) is a hydroxy monocarboxylic acid (CHEBI:35868) |
| pravastatin (CHEBI:63618) is a secondary alcohol (CHEBI:35681) |
| pravastatin (CHEBI:63618) is a statin (semi-synthetic) (CHEBI:87633) |
| pravastatin (CHEBI:63618) is conjugate acid of pravastatin(1−) (CHEBI:63660) |
| Incoming Relation(s) |
| pravastatin(1−) (CHEBI:63660) is conjugate base of pravastatin (CHEBI:63618) |
| IUPAC Name |
|---|
| (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid |
| INNs | Source |
|---|---|
| pravastatinum | ChemIDplus |
| pravastatin | ChemIDplus |
| pravastatine | ChemIDplus |
| pravastatina | ChemIDplus |
| Synonyms | Source |
|---|---|
| (+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid | ChEBI |
| pravastatin acid | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| C01844 | KEGG COMPOUND |
| D08410 | KEGG DRUG |
| DB00175 | DrugBank |
| HMDB0005022 | HMDB |
| Pravastatin | Wikipedia |
| C00000565 | KNApSAcK |
| LSM-3347 | LINCS |
| 2239 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| Reaxys:4825538 | Reaxys |
| CAS:81093-37-0 | KEGG COMPOUND |
| CAS:81093-37-0 | ChemIDplus |
| Citations |
|---|